About MIW VENTURES
MIW VENTURES is a venture capital firm founded in 2000. It is primarily based out of Ramat Gan, Israel. It primarily invests in Israel based startups. Its investments are spread across a wide range of sectors from Enterprise Applications to High Tech and Life Sciences. Overall, MIW VENTURES portfolio has seen 3 IPOs and 3 acquisitions including key companies like Gauzy, iMedX and NeuroSense Therapeutics. MIW VENTURES has team of 2 people including 2 partners.Key Metrics
Team Members
Portfolio Sectors
Portfolio Locations
Portfolio IPOs
Portfolio Soonicorns
MIW VENTURES's List of Top Investments
MIW VENTURES has a portfolio of 89 companies. Their most notable investments include Humanz and D-ID.Their portfolio spans across Israel, United States, Australia and 3 more locations. They have invested in Enterprise Applications, High Tech, Life Sciences and 25 other sectors. Here is the list of top investments by MIW VENTURES:
1. Humanz
Cloud and AI based platform offering influencer marketing solutions. The platform helps businesses in connecting influencers or content creators with advertisers that enable them to run collaborative influencer marketing campaigns to attract an audience and enhance brand awareness.
Key facts about Humanz
- Founded Year: 2017
- Location: Tel Aviv (Israel)
- Stage: Series B
- Total Funding till date: $32M
- Employee Count: 91 as on Jul 01, 2024
- Investors: Mor Investment House, MIW VENTURES and 5 Others
- Latest Funding Round: Series B, Dec 18, 2025, $*****
- Highlight: Editors' Pick

2. D-ID
Provider of a platform for generating videos using artificial intelligence. It offers tools to create AI avatars from photos or videos. It translates videos into multiple languages and facilitates personalized video campaigns. It also provides an API for integrating AI features into other applications.
Key facts about D-ID
- Founded Year: 2017
- Location: Tel Aviv (Israel)
- Stage: Series B
- Total Funding till date: $48M
- Employee Count: 51 as on Jul 01, 2024
- Investors: Hyundai Motor Company, Maverick Ventures and 22 Others
- Latest Funding Round: Series B, Mar 22, 2022, $*****
- Highlight: Editors' Pick
3. Gauzy
Developer of smart glass technologies and advanced driver assistance systems. The company researches, develops, manufactures, and markets light and vision control technologies. These technologies support user experiences in various spaces. Offerings include smart glass for architecture, automotive, and aeronautics. The company also provides camera monitor systems and collision avoidance systems.
Key facts about Gauzy
- Founded Year: 2009
- Location: Tel Aviv (Israel)
- Stage: Public
- Total Funding till date: $81.3M
- Employee Count: 83 as on Jul 01, 2024
- Investors: Schechter, Touchdown Ventures and 14 Others
- Latest Funding Round: Series D, Feb 08, 2022, $*****
- Highlight: Public
4. iMedX
RCM and clinical documentation solutions optimizing healthcare revenue and patient care. They streamline revenue cycle management and create insightful clinical documentation for physician groups and hospitals. Their solutions enable doctors to focus on patients. They offer medical coding and auditing services, ensuring accurate coding and compliance. They focus on core measures, tracking key performance indicators to improve healthcare quality. They provide clinical documentation services, converting medical dictations into clear patient records. They offer revenue cycle management solutions, improving financial processes and operational efficiency. They leverage technology and expertise to optimize operations and improve clinical outcomes. Their solutions simplify billing and insurance claims. They ensure clinical documentation is accurate and compliant. They provide data-driven insights into billing operations and clinical performance, enabling informed decisions and business growth. They offer AI medical coding, coding audits, and coding for hospitals and physician groups. They are a B2B company offering software and services.
Key facts about iMedX
- Founded Year: 2002
- Location: Atlanta (United States)
- Stage: Acquired
- Total Funding till date: $22.3M
- Employee Count: 951 as on Dec 31, 2019
- Investors: RFE Investment Partners, MIW VENTURES and 1 Other
- Latest Funding Round: Series B, Dec 24, 2013, $*****
- Highlight: Acquired
5. Fize Medica
Fize Medical develops a device for monitoring health status through urine. The company has developed a solution for real-time monitoring of urine production. Based on patented technology the solution is comprised of a platform and a module for measuring urine output.
Key facts about Fize Medica
- Founded Year: 2014
- Location: Be er Sheva (Israel)
- Stage: Series A
- Total Funding till date: $25.3M
- Employee Count: 24 as on Jul 01, 2024
- Investors: Rapha Capital Management, Hibiscus Capital Management and 5 Others
- Latest Funding Round: Series A, Dec 24, 2024, $*****
IPOs and Publicly Listed companies in MIW VENTURES's Portfolio
3 of MIW VENTURES's portfolio companies have become public. Gauzy got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ), in Jun 2024 at marketcap of $315M and NeuroSense Therapeutics got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ) at marketcap of $65.7M.Here are MIW VENTURES's portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Jun 06, 2024 | - | - | 7640 | |
Dec 09, 2021 | - | - | 3657 | |
Jan 30, 2013 | - | - | 1627 |
Acquired companies in MIW VENTURES's Portfolio
3 companies from MIW VENTURES's portfolio have been acquired. The most recent acquisition was Oolo in Dec 2023 by AppsFlyer for $*****.Here are MIW VENTURES's portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Dec 05, 2023 | - | - | 4830 | |
Jun 01, 2023 | - | - | 8629 | |
Oct 25, 2016 | - | - | 8329 |
